Healthcare >> Analyst Interviews >> February 21, 2013
Small and Midcap Medical Device Companies Benefit from Less Exposure to Europe
Steven M. Lichtman is Managing Director and Senior Analyst for medical devices at Oppenheimer & Co. Inc. Mr. Lichtman brings extensive experience in the medical devices sector, having previously held that role at JMP Securities and also Banc of America Securities LLC, where he focused on several medical device sectors, most notably orthopedics/spine. In 2007, he ranked in the top five for his orthopedics coverage in the Greenwich analyst survey. Prior to Banc of America Securities LLC, Mr. Lichtman was the Senior Associate on leading medical devices teams at Credit Suisse First Boston and Schroder & Company, Inc. Mr. Lichtman received a B.A. from Duke University in economics and public policy studies, and an MBA from New York University’s Stern School of Business. Profile
TWST: Where are you focusing your attention in the medical device space these days?
Mr. Lichtman: I cover 15 stocks, both large- and small-cap companies, and the majority are small